Logo image of LNSR

LENSAR INC (LNSR) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:LNSR - US52634L1089 - Common Stock

10.27 USD
+0.02 (+0.2%)
Last: 12/2/2025, 4:30:00 PM
10.27 USD
0 (0%)
After Hours: 12/2/2025, 4:30:00 PM
Fundamental Rating

2

Taking everything into account, LNSR scores 2 out of 10 in our fundamental rating. LNSR was compared to 188 industry peers in the Health Care Equipment & Supplies industry. LNSR has a bad profitability rating. Also its financial health evaluation is rather negative. LNSR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year LNSR has reported negative net income.
LNSR had a negative operating cash flow in the past year.
In the past 5 years LNSR always reported negative net income.
In the past 5 years LNSR always reported negative operating cash flow.
LNSR Yearly Net Income VS EBIT VS OCF VS FCFLNSR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

LNSR has a Return On Assets of -73.39%. This is in the lower half of the industry: LNSR underperforms 74.47% of its industry peers.
Industry RankSector Rank
ROA -73.39%
ROE N/A
ROIC N/A
ROA(3y)-34.59%
ROA(5y)-31.65%
ROE(3y)-81.1%
ROE(5y)-61.69%
ROIC(3y)N/A
ROIC(5y)N/A
LNSR Yearly ROA, ROE, ROICLNSR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1.3 Margins

Looking at the Gross Margin, with a value of 46.15%, LNSR is doing worse than 60.11% of the companies in the same industry.
In the last couple of years the Gross Margin of LNSR has grown nicely.
The Profit Margin and Operating Margin are not available for LNSR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.25%
GM growth 5Y2.2%
LNSR Yearly Profit, Operating, Gross MarginsLNSR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

1

2. Health

2.1 Basic Checks

LNSR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LNSR has been increased compared to 1 year ago.
The number of shares outstanding for LNSR has been increased compared to 5 years ago.
There is no outstanding debt for LNSR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LNSR Yearly Shares OutstandingLNSR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
LNSR Yearly Total Debt VS Total AssetsLNSR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -2.61, we must say that LNSR is in the distress zone and has some risk of bankruptcy.
LNSR's Altman-Z score of -2.61 is on the low side compared to the rest of the industry. LNSR is outperformed by 62.77% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.61
ROIC/WACCN/A
WACC8.73%
LNSR Yearly LT Debt VS Equity VS FCFLNSR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 1.24 indicates that LNSR should not have too much problems paying its short term obligations.
LNSR has a worse Current ratio (1.24) than 81.91% of its industry peers.
LNSR has a Quick Ratio of 1.24. This is a bad value and indicates that LNSR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of LNSR (0.67) is worse than 89.36% of its industry peers.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 0.67
LNSR Yearly Current Assets VS Current LiabilitesLNSR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

6

3. Growth

3.1 Past

LNSR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -200.68%.
Looking at the last year, LNSR shows a very strong growth in Revenue. The Revenue has grown by 21.02%.
Measured over the past years, LNSR shows a quite strong growth in Revenue. The Revenue has been growing by 11.87% on average per year.
EPS 1Y (TTM)-200.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-138.46%
Revenue 1Y (TTM)21.02%
Revenue growth 3Y15.79%
Revenue growth 5Y11.87%
Sales Q2Q%5.74%

3.2 Future

The Earnings Per Share is expected to grow by 29.52% on average over the next years. This is a very strong growth
LNSR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 32.11% yearly.
EPS Next Y89.88%
EPS Next 2Y41.69%
EPS Next 3Y29.52%
EPS Next 5YN/A
Revenue Next Year32.69%
Revenue Next 2Y32.89%
Revenue Next 3Y32.11%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LNSR Yearly Revenue VS EstimatesLNSR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
LNSR Yearly EPS VS EstimatesLNSR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6 -8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

LNSR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 503.43, which means the current valuation is very expensive for LNSR.
62.77% of the companies in the same industry are more expensive than LNSR, based on the Price/Forward Earnings ratio.
LNSR is valuated expensively when we compare the Price/Forward Earnings ratio to 36.21, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 503.43
LNSR Price Earnings VS Forward Price EarningsLNSR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300 400 500

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LNSR Per share dataLNSR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as LNSR's earnings are expected to grow with 29.52% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.69%
EPS Next 3Y29.52%

More info and screens

0

5. Dividend

5.1 Amount

LNSR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LENSAR INC

NASDAQ:LNSR (12/2/2025, 4:30:00 PM)

After market: 10.27 0 (0%)

10.27

+0.02 (+0.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-25 2026-02-25/bmo
Inst Owners47.87%
Inst Owner Change4.07%
Ins Owners19.7%
Ins Owner Change0%
Market Cap122.62M
Revenue(TTM)59.14M
Net Income(TTM)-51.52M
Analysts45.71
Price Target15.3 (48.98%)
Short Float %6.81%
Short Ratio11.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-301.96%
Min EPS beat(2)-507.84%
Max EPS beat(2)-96.08%
EPS beat(4)0
Avg EPS beat(4)-687.06%
Min EPS beat(4)-1367.43%
Max EPS beat(4)-96.08%
EPS beat(8)2
Avg EPS beat(8)-359.42%
EPS beat(12)4
Avg EPS beat(12)-250.66%
EPS beat(16)8
Avg EPS beat(16)-183.01%
Revenue beat(2)0
Avg Revenue beat(2)-18.62%
Min Revenue beat(2)-19.8%
Max Revenue beat(2)-17.45%
Revenue beat(4)2
Avg Revenue beat(4)-5.89%
Min Revenue beat(4)-19.8%
Max Revenue beat(4)10.09%
Revenue beat(8)4
Avg Revenue beat(8)-1.11%
Revenue beat(12)6
Avg Revenue beat(12)-0.65%
Revenue beat(16)8
Avg Revenue beat(16)0.36%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)17.65%
EPS NY rev (1m)0%
EPS NY rev (3m)30.77%
Revenue NQ rev (1m)-1.46%
Revenue NQ rev (3m)-0.73%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 503.43
P/S 2.07
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.39
EYN/A
EPS(NY)0.02
Fwd EY0.2%
FCF(TTM)-0.99
FCFYN/A
OCF(TTM)-0.99
OCFYN/A
SpS4.95
BVpS-1.02
TBVpS-1.47
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -73.39%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.15%
FCFM N/A
ROA(3y)-34.59%
ROA(5y)-31.65%
ROE(3y)-81.1%
ROE(5y)-61.69%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.25%
GM growth 5Y2.2%
F-Score3
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.94%
Cap/Sales 0.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.24
Quick Ratio 0.67
Altman-Z -2.61
F-Score3
WACC8.73%
ROIC/WACCN/A
Cap/Depr(3y)4.73%
Cap/Depr(5y)8.26%
Cap/Sales(3y)0.4%
Cap/Sales(5y)0.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-200.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-138.46%
EPS Next Y89.88%
EPS Next 2Y41.69%
EPS Next 3Y29.52%
EPS Next 5YN/A
Revenue 1Y (TTM)21.02%
Revenue growth 3Y15.79%
Revenue growth 5Y11.87%
Sales Q2Q%5.74%
Revenue Next Year32.69%
Revenue Next 2Y32.89%
Revenue Next 3Y32.11%
Revenue Next 5YN/A
EBIT growth 1Y-143.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year95.65%
EBIT Next 3Y40.8%
EBIT Next 5YN/A
FCF growth 1Y16.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.41%
OCF growth 3YN/A
OCF growth 5YN/A

LENSAR INC / LNSR FAQ

What is the ChartMill fundamental rating of LENSAR INC (LNSR) stock?

ChartMill assigns a fundamental rating of 2 / 10 to LNSR.


What is the valuation status for LNSR stock?

ChartMill assigns a valuation rating of 1 / 10 to LENSAR INC (LNSR). This can be considered as Overvalued.


How profitable is LENSAR INC (LNSR) stock?

LENSAR INC (LNSR) has a profitability rating of 1 / 10.


What is the earnings growth outlook for LENSAR INC?

The Earnings per Share (EPS) of LENSAR INC (LNSR) is expected to grow by 89.88% in the next year.